Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial

Rationale: Aspirin-exacerbated respiratory disease is characterized by severe asthma, nonsteroidal antiinflammatory drug hypersensitivity, nasal polyposis, and leukotriene overproduction. Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab effic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Respir Crit Care Med
Autores principales: Hayashi, Hiroaki, Fukutomi, Yuma, Mitsui, Chihiro, Kajiwara, Keiichi, Watai, Kentaro, Kamide, Yosuke, Nakamura, Yuto, Hamada, Yuto, Tomita, Yasuhiro, Sekiya, Kiyoshi, Tsuburai, Takahiro, Izuhara, Kenji, Wakahara, Keiko, Hashimoto, Naozumi, Hasegawa, Yoshinori, Taniguchi, Masami
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301746/
https://ncbi.nlm.nih.gov/pubmed/32142372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1215OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares